GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Formosa Laboratories 4746.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

44.70

+2.17%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 4.85bn

FY2016FY2025

Net income

TWD 441.1m

FY2016FY2025

Free cash flow

TWD 472.1m

FY2016FY2025

Shareholders' equity

TWD 7.76bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 4.85bnTWD 4.73bnTWD 4.36bnTWD 3.77bnTWD 3.14bnTWD 3.08bnTWD 2.76bnTWD 2.69bnTWD 2.54bnTWD 3.19bn
Gross profitTWD 2.03bnTWD 2.05bnTWD 1.92bnTWD 1.39bnTWD 971.4mTWD 945.2mTWD 825.3mTWD 914.1mTWD 1.01bnTWD 1.26bn
Research and developmentTWD 727.9mTWD 796.4mTWD 841.9mTWD 777.0mTWD 700.2mTWD 548.2mTWD 446.4mTWD 459.0mTWD 294.6mTWD 271.8m
Operating incomeTWD 803.2mTWD 750.0mTWD 675.0mTWD 380.8mTWD 1.10bnTWD 420.4m−TWD 11.5mTWD 57.2mTWD 378.2mTWD 663.4m
Net incomeTWD 441.1mTWD 157.3mTWD 126.2mTWD 216.8mTWD 1.25bnTWD 400.0m−TWD 41.1mTWD 176.8mTWD 238.6mTWD 483.4m
Diluted earnings per share4.291.311.051.7910.393.69-0.411.812.555.42

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 13.83bnTWD 13.90bnTWD 13.64bnTWD 12.75bnTWD 12.02bnTWD 10.29bnTWD 9.61bnTWD 8.73bnTWD 7.24bnTWD 6.73bn
Cash and short-term investmentsTWD 2.49bnTWD 2.70bnTWD 2.51bnTWD 1.63bnTWD 1.09bnTWD 812.2mTWD 479.9mTWD 877.7mTWD 618.5mTWD 347.5m
Total liabilitiesTWD 5.16bnTWD 5.25bnTWD 5.43bnTWD 4.95bnTWD 4.41bnTWD 5.00bnTWD 5.15bnTWD 4.17bnTWD 3.14bnTWD 2.63bn
DebtTWD 3.53bnTWD 3.90bnTWD 4.06bnTWD 3.80bnTWD 3.42bnTWD 3.48bnTWD 4.15bnTWD 3.21bnTWD 2.15bnTWD 1.86bn
Shareholders' equityTWD 7.76bnTWD 7.68bnTWD 7.57bnTWD 7.52bnTWD 7.40bnTWD 5.21bnTWD 4.36bnTWD 4.41bnTWD 4.02bnTWD 4.10bn
Shares outstanding103m120m120m121m120m108m99m98m94m89m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.32bnTWD 726.3mTWD 826.6mTWD 643.1mTWD 311.2mTWD 475.0mTWD 289.9m−TWD 80.9mTWD 395.4mTWD 1.11bn
Capital spending−TWD 843.1m−TWD 587.9m−TWD 540.5m−TWD 440.0m−TWD 513.8m−TWD 1.01bn−TWD 1.42bn−TWD 1.00bn−TWD 473.2m−TWD 461.6m
Free cash flowTWD 472.1mTWD 138.5mTWD 286.1mTWD 203.1m−TWD 202.7m−TWD 536.2m−TWD 1.13bn−TWD 1.08bn−TWD 77.7mTWD 648.5m
Dividends paid−TWD 360.8m−TWD 240.5m−TWD 120.3m−TWD 240.5m−TWD 240.5m−TWD 240.5m−TWD 49.5m−TWD 186.0m−TWD 267.6m−TWD 174.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.11bnTWD 1.06bnTWD 1.30bnTWD 1.16bnTWD 1.24bnTWD 1.14bnTWD 1.35bnTWD 1.03bn
Gross profitTWD 433.8mTWD 450.8mTWD 542.4mTWD 491.8mTWD 517.0mTWD 480.9mTWD 559.7mTWD 424.2m
Operating incomeTWD 86.1mTWD 51.6mTWD 278.7mTWD 178.6mTWD 181.4mTWD 185.0mTWD 262.2mTWD 25.7m
Net income−TWD 14.5mTWD 18.8mTWD 147.3mTWD 324.1m−TWD 150.9mTWD 120.5m−TWD 53.0mTWD 22.4m
Diluted earnings per share-0.120.151.433.15-1.471.17-0.440.19
Cash from operationsTWD 90.0mTWD 156.0mTWD 298.0mTWD 276.0mTWD 299.0mTWD 441.0mTWD 282.0mTWD 283.0m
Capital spending−TWD 434.0m−TWD 241.0m−TWD 352.0m−TWD 155.0m−TWD 167.0m−TWD 167.0m−TWD 149.0m−TWD 180.0m
Free cash flow−TWD 344.0m−TWD 85.0m−TWD 54.0mTWD 121.0mTWD 132.0mTWD 274.0mTWD 133.0mTWD 103.0m
Total assetsTWD 13.91bnTWD 13.70bnTWD 13.83bnTWD 13.54bnTWD 13.58bnTWD 13.87bnTWD 13.90bnTWD 13.94bn
Cash and short-term investmentsTWD 2.07bnTWD 2.38bnTWD 2.49bnTWD 2.45bnTWD 2.62bnTWD 2.89bnTWD 2.70bnTWD 2.57bn
DebtTWD 710.2mTWD 3.52bnTWD 3.53bnTWD 3.44bnTWD 3.42bnTWD 3.71bnTWD 3.82bnTWD 3.80bn
Shareholders' equityTWD 7.43bnTWD 7.78bnTWD 7.76bnTWD 7.62bnTWD 7.29bnTWD 7.81bnTWD 7.68bnTWD 7.75bn

Financial ratios

Data as of 11 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin41.9%43.3%44.1%36.9%30.9%30.7%
Operating margin16.6%5.1%15.5%9.4%35.1%13.7%
Net margin9.1%3.3%2.9%5.8%39.7%13.0%
Return on equity5.7%2.0%1.7%2.9%16.9%7.7%
Return on assets3.2%1.1%0.9%1.7%10.4%3.9%
Free cash flow yield42.9%22.3%23.2%18.3%14.0%28.0%
Revenue growth2.5%8.5%15.8%19.8%2.2%11.4%
Earnings growth180.5%24.6%-41.8%-82.6%212.2%-1074.2%
Current ratio1.91x2.49x1.62x1.32x1.52x1.04x
Debt to equity0.45x0.50x0.53x0.50x0.46x0.80x
Equity ratio56.1%55.3%55.5%59.0%61.5%50.6%
Interest coverage24.25x6.06x19.43x18.25x39.36x14.80x
R&D as a share of sales15.0%16.8%19.3%20.6%22.3%17.8%
Buybacks as a share of market value14.6%0.0%0.5%-0.6%-10.8%-9.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.8%9.5%6.4%
Operating income28.2%13.8%9.5%
Net income26.7%2.0%4.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.6%41.8%38.9%37.5%
Operating margin16.2%14.7%17.3%14.7%
Net margin6.2%5.3%10.8%9.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.852.697.241.05.812.7-100.421.026.718.2
Price to sales1.31.82.82.42.31.71.51.42.52.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 24 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2019FY2018FY2017
Paid in the year3.003.002.001.002.000.4951.9722.838

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.